Renly Lim

1.4k total citations
70 papers, 726 citations indexed

About

Renly Lim is a scholar working on Geriatrics and Gerontology, Rheumatology and Surgery. According to data from OpenAlex, Renly Lim has authored 70 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Geriatrics and Gerontology, 17 papers in Rheumatology and 12 papers in Surgery. Recurrent topics in Renly Lim's work include Pharmaceutical Practices and Patient Outcomes (19 papers), Pelvic floor disorders treatments (17 papers) and Urinary Bladder and Prostate Research (12 papers). Renly Lim is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (19 papers), Pelvic floor disorders treatments (17 papers) and Urinary Bladder and Prostate Research (12 papers). Renly Lim collaborates with scholars based in Australia, Malaysia and Netherlands. Renly Lim's co-authors include Kah Hay Yuen, Men Long Liong, Wing Seng Leong, Elizabeth E. Roughead, Lisa Kalisch Ellett, Nurzalina Abdul Karim Khan, Susan J. Semple, Nicole Pratt, Einly Lim and Ka Keat Lim and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and Journal of the American Geriatrics Society.

In The Last Decade

Renly Lim

61 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renly Lim Australia 17 284 210 190 166 99 70 726
Scott Martin Vouri United States 16 83 0.3× 97 0.5× 115 0.6× 226 1.4× 196 2.0× 87 977
Elke Jeschke Germany 18 39 0.1× 329 1.6× 52 0.3× 47 0.3× 71 0.7× 55 825
J. Mark Ruscin United States 16 120 0.4× 151 0.7× 17 0.1× 227 1.4× 64 0.6× 23 1.0k
Ivy O. Poon United States 10 29 0.1× 174 0.8× 35 0.2× 177 1.1× 34 0.3× 29 606
Gero Langer Germany 17 39 0.1× 211 1.0× 23 0.1× 38 0.2× 162 1.6× 72 1.0k
Satabdi Chatterjee United States 15 36 0.1× 53 0.3× 32 0.2× 228 1.4× 18 0.2× 37 552
Johanna Ulfvarson Sweden 14 23 0.1× 74 0.4× 23 0.1× 179 1.1× 48 0.5× 29 498
Nicole Vogt-Ferrier Switzerland 11 48 0.2× 18 0.1× 37 0.2× 226 1.4× 36 0.4× 24 547
Christopher M. Herndon United States 15 37 0.1× 171 0.8× 15 0.1× 96 0.6× 217 2.2× 46 875
Cihan Kılıç Türkiye 17 46 0.2× 102 0.5× 10 0.1× 410 2.5× 52 0.5× 41 880

Countries citing papers authored by Renly Lim

Since Specialization
Citations

This map shows the geographic impact of Renly Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renly Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renly Lim more than expected).

Fields of papers citing papers by Renly Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renly Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renly Lim. The network helps show where Renly Lim may publish in the future.

Co-authorship network of co-authors of Renly Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Renly Lim. A scholar is included among the top collaborators of Renly Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renly Lim. Renly Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dedefo, Mohammed Gebre, Gizat M. Kassie, Eyob Alemayehu Gebreyohannes, et al.. (2025). Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries. Pharmacology Research & Perspectives. 13(4). e70164–e70164.
2.
Dedefo, Mohammed Gebre, Gizat M. Kassie, Eyob Alemayehu Gebreyohannes, et al.. (2025). Completeness of spontaneously reported adverse drug reactions in 4 databases. British Journal of Clinical Pharmacology. 91(12). 3389–3400. 1 indexed citations
3.
Mekuria, Abebe Basazn, Henok Getachew Tegegn, André Q Andrade, et al.. (2025). Patient reported tools for assessing potential medicine-related symptoms: A systematic review. Research in Social and Administrative Pharmacy. 21(4). 193–204. 1 indexed citations
4.
Brown, Peter, Tahlia R. Meola, Dorothea Dumuid, et al.. (2024). A Digitally Enabled, Pharmacist service to detecT medicine harms in residential aged care (nursing home) (ADEPT): protocol for a feasibility study. BMJ Open. 14(2). e080148–e080148. 2 indexed citations
5.
Ellett, Lisa Kalisch, et al.. (2024). Innovations in pharmacovigilance studies of medicines in older people. British Journal of Clinical Pharmacology. 91(1). 66–83.
6.
Stehlik, Paulina, Caroline Dowsett, Ximena Camacho, et al.. (2024). Evol ution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: a sc oping r eview protocol. BMJ Open. 14(3). e079071–e079071. 2 indexed citations
7.
Dedefo, Mohammed Gebre, Renly Lim, Gizat M. Kassie, Elizabeth E. Roughead, & Lisa Kalisch Ellett. (2024). Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey. European Journal of Clinical Pharmacology. 80(10). 1543–1554. 5 indexed citations
8.
Dedefo, Mohammed Gebre, Renly Lim, Gizat M. Kassie, et al.. (2024). Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study. International Journal of Clinical Pharmacy. 47(2). 423–434. 1 indexed citations
9.
Gebreyohannes, Eyob Alemayehu, Sieta T. de Vries, André Q Andrade, et al.. (2024). Co-Designing a Consumer-Focused Digital Reporting Health Platform to Improve Adverse Medicine Event Reporting: Protocol for a Multimethod Research Project (the ReMedi Project). JMIR Research Protocols. 14. e60084–e60084. 1 indexed citations
10.
Rowett, Debra, et al.. (2023). Clinical pharmacists’ participation in ward rounds in hospitals: responses from a national survey. International Journal of Pharmacy Practice. 31(4). 409–416. 5 indexed citations
11.
Ellett, Lisa Kalisch, Gereltuya Dorj, André Q Andrade, et al.. (2023). Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR Trial. Drug Safety. 46(5). 493–500. 4 indexed citations
12.
Lim, Renly, Lisa Kalisch Ellett, Susan J. Semple, & Elizabeth E. Roughead. (2022). The Extent of Medication-Related Hospital Admissions in Australia: A Review from 1988 to 2021. Drug Safety. 45(3). 249–257. 61 indexed citations
13.
Lim, Renly, et al.. (2022). Development of a Web-Based System to Report Medication-Related Adverse Effects: Design and Usability Study. JMIR Formative Research. 6(10). e37605–e37605. 4 indexed citations
14.
Oliveira, Raquel de Vasconcellos Carvalhães de, et al.. (2022). How are groups of early career pharmacists and pharmaceutical scientists contributing to global health and policy development: A cross-sectional survey. Research in Social and Administrative Pharmacy. 19(4). 615–621. 3 indexed citations
15.
Lim, Renly, Thu‐Lan Kelly, André Q Andrade, et al.. (2022). Frailty trajectory over one year among residential aged care (nursing home) residents. Frontiers in Medicine. 9. 1010444–1010444. 3 indexed citations
16.
Dawoud, Dalia, Pedro Amariles, John Jackson, et al.. (2020). Pharmacy Practice Research. Pharmacy Education. 20(3). 91–132. 1 indexed citations
17.
Manikkath, Jyothsna, et al.. (2020). Exploring young pharmacists' and pharmaceutical scientists' needs and expectations within an international pharmacy organization: Findings from FIP's needs assessment survey. Research in Social and Administrative Pharmacy. 16(12). 1677–1685. 3 indexed citations
18.
Lim, Renly, Men Long Liong, Ka Keat Lim, Wing Seng Leong, & Kah Hay Yuen. (2019). The Minimum Clinically Important Difference of the International Consultation on Incontinence Questionnaires (ICIQ-UI SF and ICIQ-LUTSqol). Urology. 133. 91–95. 46 indexed citations
19.
Lim, Renly, Mhairi Kerr, & Elizabeth E. Roughead. (2018). Use of medicines and health services for chronic obstructive pulmonary disease among a cohort of Australians over 50 years. International Journal of COPD. Volume 13. 3085–3093. 3 indexed citations
20.
Lim, Renly, et al.. (2017). The Impact of Stress Urinary Incontinence on Individual Components of Quality of Life in Malaysian Women. Urology. 112. 38–45. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026